Get the Stockscreener App
17.90
2.51%
-0.46
After Hours:
17.90
Assembly Biosciences Inc stock is traded at $17.90, with a volume of 16,146.
It is down -2.51% in the last 24 hours and down -1.21% over the past month.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
See More
Previous Close:
$18.36
Open:
$18.62
24h Volume:
16,146
Relative Volume:
0.58
Market Cap:
$136.71M
Revenue:
-
Net Income/Loss:
$-61.23M
P/E Ratio:
-1.324
EPS:
-13.5194
Net Cash Flow:
$22.49M
1W Performance:
-2.35%
1M Performance:
-1.21%
6M Performance:
+24.05%
1Y Performance:
+24.13%
1-Day Range:
$17.73
$18.93
1-Week Range:
$17.73
$19.50
52-Week Range:
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
Name
Assembly Biosciences Inc
Sector
Industry
Phone
(833) 409-4583
Address
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
17.90 | 148.93M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.16 | 118.34B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.58 | 60.31B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.80 | 42.35B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.89 | 36.43B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.94 | 31.87B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-25 | Initiated | Guggenheim | Buy |
| Sep-20-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Neutral |
| Sep-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Nov-06-20 | Downgrade | Jefferies | Buy → Hold |
| Oct-19-20 | Initiated | Truist | Buy |
| Oct-16-19 | Initiated | Mizuho | Buy |
| Nov-19-18 | Initiated | Leerink Partners | Outperform |
| Oct-08-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Aug-08-18 | Initiated | Robert W. Baird | Outperform |
| Apr-13-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-05-18 | Initiated | B. Riley FBR, Inc. | Neutral |
| Nov-08-17 | Initiated | Jefferies | Buy |
| May-30-17 | Initiated | Chardan Capital Markets | Buy |
View All
Assembly Biosciences Inc Stock (ASMB) Latest News
How Assembly Biosciences Inc. stock performs during market volatilityPortfolio Positioning Strategy With Timing - Newser
Long term hold vs stop loss in Assembly Biosciences Inc.Investment Position Summary with Timeframe Forecast - Newser
Analyzing net buyer seller activity in Assembly Biosciences Inc.Top Stock Picks with Forecast Accuracy - Newser
Is Assembly Biosciences Inc. stock poised for growthInvestment Position Summary with Timeframe Forecast - Newser
Moving Average Trends for Assembly Biosciences Inc. Stock: What They IndicateMomentum Stocks with Breakout Potential - Newser
Published on: 2025-07-29 17:33:24 - metal.it
Assembly Biosciences Inc. Shows Support at Fibonacci LevelChart Breakout Buy Signal Detection Confirmed - metal.it
How Efficient Is Assembly Biosciences Inc. at Controlling Operating CostsFree Watchlist for Low Risk High Return - Newser
How Resilient Is Assembly Biosciences Inc. Stock During Economic DownturnsFree Fast Entry High Potential Stock Alerts - Newser
What makes Assembly Biosciences Inc. stock price move sharplyFree Accurate Technical Trend Reversal Picks - Newser
Combining price and volume data for Forte Biosciences Inc.Trade Flow Monitor with Volume Tracker - Newser
Is This the Dip to Buy in Assembly Biosciences Inc.AI Forecast for Trending Stocks Indicates Upside - metal.it
Assembly Biosciences Inc. Included in Top Momentum ScanChart Breakout Buy Signal Detection Confirmed - metal.it
News impact scoring models applied to Compass Inc.Free Real-Time Analysis With Entry Targets - Newser
Real time breakdown of Assembly Biosciences Inc. stock performanceSmart Stock Forecast Using AI Algorithms - Newser
How does Assembly Biosciences Inc. compare to its industry peersMaximize your gains with expert trading tips - jammulinksnews.com
Should I hold or sell Assembly Biosciences Inc. stock in 2025Get professional advice for portfolio optimization - jammulinksnews.com
When is Assembly Biosciences Inc. stock expected to show significant growthDiscover dynamic stocks ready to soar - jammulinksnews.com
Does Assembly Biosciences Inc. stock perform well during market downturnsGain access to exclusive stock analysis - jammulinksnews.com
What makes Arteris Inc. stock price move sharplyFree Stock Market Knowledge Sharing - Newser
Assembly Biosciences Inc. Earnings Report Breakdown: What Investors Should KnowProven Return Strategy Execution - Newser
Competitive Positioning of Assembly Biosciences Inc.: Is It Leading or LaggingRisk Adjusted Stock Signals - Newser
Published on: 2025-07-27 15:23:50 - jammulinksnews.com
The Best Artificial Intelligence (AI) Stock to Buy With the Market At All-Time Highs - The Globe and Mail
Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop - The Manila Times
Assembly Biosciences Presents Data Highlighting Recurrent Genita - GuruFocus
Assembly Biosciences Presents Phase 1a Clinical Data for Novel HSV Inhibitors ABI-5366 and ABI-1179 at World Congress and Herpesvirus Workshop - Quiver Quantitative
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences Inc. Stock Analysis and ForecastMassive wealth growth - PrintWeekIndia
NVE Corp Q1 Earnings Decline Y/Y, Stock Falls More Than 20% - The Globe and Mail
Will Poor Segmental Sales Performance Impact HII's Q2 Earnings? - The Globe and Mail
When is the best time to buy Assembly Biosciences Inc. stockHigh-yield capital appreciation - jammulinksnews.com
Why Assembly Biosciences Inc. stock attracts strong analyst attentionSafe Entry High Exit Alerts - Newser
What analysts say about Apollo Global Management Inc. stockFree Stock Chart Pattern Guide - Autocar Professional
Assembly Bio's HBV drug shows strong efficacy in Phase 1b trial, sets stage for licensing decision with Gilead Sciences. - AInvest
Praxis Home Retail Limited (PRAXIS) Expands into New MarketExplosive earning power - Autocar Professional
Intel Corporation Stock Analysis and ForecastSkyrocketing investment returns - Autocar Professional
Vicor’s Q2 2025 Earnings Call: Growth Amid Challenges - The Globe and Mail
What drives Assembly Biosciences Inc. stock priceRapid wealth multiplication - jammulinksnews.com
ClearVue Technologies Partners with Erbas to Advance Decarbonization in Building Design - The Globe and Mail
11 Growth Stocks That Could Double by 2027 - Insider Monkey
Is Xcel Energy Inc. a good long term investmentPowerful profit generation - Autocar Professional
What drives NATR stock priceFree Stock Index Interpretation - jammulinksnews.com
Assembly Biosciences Inc Stock (ASMB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.23%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):